FGBL:PA:PA- (EUR)

ETF | Others |

Last Closing

USD 57.85

Change

+0.96 (+1.69)%

Market Cap

USD 2.03M

Volume

3.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.07 (-0.17%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-6.85 (-1.43%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-5.56 (-1.62%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.37 (-1.16%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.45 (-0.19%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-8.05 (-1.97%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-3.87 (-1.24%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.70 (-1.45%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.20 (-3.31%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.53 (-0.70%)

USD 5.54B

ETFs Containing FGBL:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.74% 62% D 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.74% 61% D- 55% F
Trailing 12 Months  
Capital Gain -0.52% 56% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.52% 53% F 60% D-
Trailing 5 Years  
Capital Gain 55.57% 54% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.57% 51% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 11.18% 64% D 68% D+
Dividend Return 11.18% 62% D 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.56% 66% D+ 90% A-
Risk Adjusted Return 117.02% 92% A 96% N/A
Market Capitalization 2.03M 1% F 4% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.